Alector, Inc. is a clinical-stage biopharmaceutical company. The Company is focused on immuno-neurology, a novel therapeutic approach for the treatment of neurodegeneration. Immuno-neurology targets immune dysfunction as a cause of multiple pathologi... Read more
CNBC
SeekingAlpha
CNBC
MarketWatch
Access detailed stock analysis from LSEG including analyst price target estimates.